Bezel Pharma Pvt Ltd
About Bezel Pharma Pvt Ltd
Data last updated:
Bezel Pharma Pvt Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 August 1982 and has been in existence for over 44 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U45100MH1982PTC028103. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors Sachin Navinchandra Doshi and Chetan Bhupatray Dani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 99 Kandivaligovt Industrial Estate Kandivali (W), Mumbai, Maharashtra, India – 400067.
As per the financials filed for FY 2025, the company reported a revenue of ₹93,706, a growth of 18% compared to the previous year. For the same year it recorded a net loss of ₹30,180 (net margin -32.2%) and EBITDA of -₹30,180 (EBITDA margin -32.2%). Revenue has declined at a compounded annual rate (CAGR) of 44% over three years.
As per MCA filings, the company has satisfied charges of ₹30 Lakh on record. Court records list 7 cases involving the company, including 1 filed by the company and 6 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Bezel Pharma has one previous CIN (Corporate Identification Number): U24239MH1982PTC028103. The current CIN is U45100MH1982PTC028103, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U45100MH1982PTC028103 | Current |
| U24239MH1982PTC028103 | Previous |
Contact details
Bezel Pharma Pvt Ltd's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address99 Kandivaligovt Industrial Estate Kandivali (W), Mumbai, Maharashtra, India – 400067
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bezel Pharma Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Bezel Pharma Pvt Ltd
FY 2025 filings availableBezel Pharma Pvt Ltd reported revenue of ₹93,706 (up 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 18% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 44%. EBITDA rose 36% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹30,180 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹30,180 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -32.2% | ||||
| Net Profit Margin | -32.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bezel Pharma Pvt Ltd, buy the company report.
Board of directors of Bezel Pharma Pvt Ltd
Bezel Pharma has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sachin Navinchandra Doshi Also directs: Adore Pharmaceuticals Pvt Ltd, DWD Pharmaceuticals Limited, Noetic Finance Private Limited and 3 more | Director | 01 Jul 2008 | 18 Years 3 Months | Current |
| Chetan Bhupatray Dani | Director | 02 Sep 2002 | 24 Years 1 Months | Current |
Peer comparison
Bezel Pharma Pvt Ltd is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Oxeeco Meditek Private Limited | ₹96,499 (FY 2024) | 34.0% | Sanathnagar, Hyderabad, Telangana, India | |||
| Prakash Mother and Child Hospital Private Limited | ₹95,506 (FY 2025) | -89.0% | Jaipur, Rajasthan, India | |||
| Koye Endeavours Private Limited | ₹95,450 (FY 2025) | 99.0% | Mumbai, Maharashtra, India | |||
| Lorda Pharmaceuticals Private Limited | ₹94,569 (FY 2016) | -33.0% | Mumbai, Maharashtra, India | |||
| Excel Healthcare Private Limited | ₹94,529 (FY 2018) | Mehsana, Gujarat, India | ||||
| Bezel Pharma Pvt Ltdthis company | ₹93,706 (FY 2025) | -₹30,180 | -32.2% | 18.0% | Mumbai, Maharashtra, India | |
| Gencor Cultech India Private Limited | ₹92,572 (FY 2021) | Chennai, Tamil Nadu, India | ||||
| Associated Auxichem Private Limited | ₹91,626 (FY 2025) | Mumbai, Maharashtra, India | ||||
| Bravo Healthcare Limited | ₹91,496 (FY 2018) | -22.0% | Navi Mumbai, Maharashtra, India | |||
| Hopegen Pharma Private Limited | ₹90,720 (FY 2025) | Bhubaneswar, Odisha, India | ||||
| Suparshva Pharma Private Limited | ₹90,100 (FY 2025) | Mumbai, Maharashtra, India |
To see the full peer comparison of Bezel Pharma Pvt Ltd, buy the company report.
Auditor
Bezel Pharma Pvt Ltd is audited by C S MEHTA & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C S MEHTA & CO | FY 2019 | 106199W |
Shareholding
The shareholding of Bezel Pharma Pvt Ltd is on record for 4 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Bezel Pharma Pvt Ltd, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Sep 1984 | 90373212 | Canara Bank | ₹30 Lakh | Satisfied |
To see the full charge records of Bezel Pharma Pvt Ltd, buy the company report.
Total charge records: 1 View all charges
Legal cases
Bezel Pharma Pvt Ltd has 7 court cases on record: 1 filed by Bezel Pharma, 6 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 5 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 7)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed by the company against Kandivali Co-Operative Industrial Estate Limited and Ors. and 7 others | Disposed |
| Bombay High Court | Tax appeal | Filed against the company by The Commissioner of Income Tax-9,Mumbai. | Disposed |
| Bombay High Court | Tax appeal | Filed against the company by The Commissioner of Income-Tax-9,Mumbai. | Disposed |
| Bombay High Court | Tax appeal | Filed against the company by The Commissioner of Income Tax 9 Mumbai | Disposed |
| Supreme Court | Court case (0433-Indirect Taxes Matters : Appeals u/s 35 L of Central Excise and Salt Act, 1944.) | Filed against the company by an individual | Disposed |
To see the full case history of Bezel Pharma Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Bezel Pharma Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Bezel Pharma Pvt Ltd has 1 active EPFO establishment as of Apr 07, 2024.
GST
Bezel Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Bezel Pharma Pvt Ltd, buy the company report.
Recent activity
Bezel Pharma Pvt Ltd has 7 board changes on record since 2002: 2 appointments and 5 cessations. The latest: Navin Bachubhai Doshi ceased to be Director on 15 Nov 2017.
Frequently asked questions
Bezel Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 August 1982 (44+ years old) and is registered under CIN U45100MH1982PTC028103.
Bezel Pharma has 2 current directors:
- Sachin Navinchandra Doshi - Director
- Chetan Bhupatray Dani - Director
The latest financial statements of Bezel Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
No. Bezel Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Bezel Pharma is U45100MH1982PTC028103. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bezel Pharma has 7 court cases on record: 1 filed by the company and 6 filed against it. Most are in the high courts.
Bezel Pharma was incorporated on 30 August 1982, making it 44+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Bezel Pharma by revenue are Oxeeco Meditek Private Limited, Prakash Mother and Child Hospital Private Limited, Koye Endeavours Private Limited, Lorda Pharmaceuticals Private Limited, Excel Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations).
Navin Bachubhai Doshi ceased to be Director on 15 Nov 2017. Chetan Navinchandra Doshi ceased to be Director on 14 Aug 2017. Priyushchnadra Ratilal Dhedhi ceased to be Director on 14 Aug 2014. Bezel Pharma has 7 board changes on record in total.
The registered office of Bezel Pharma is at 99 Kandivaligovt Industrial Estate Kandivali W, Mumbai, Maharashtra, India – 400067.
Bezel Pharma operates in the pharma industry, in the drug formulation and development segment.